The results of a multicentre double-blind trial are reported in which α-[4-(1,1-dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebut anol (terfenadine, RMI 9918, Triludan®, Teldane®, resp.) and dexchlorpheniramine were compared with placebo in the treatment of allergic rhinitis. Terfenadine and dexchlorpheniramine were found to be equally effective; but terfenadine produced less drowsiness and was effective in a twice daily dosage.
|Titolo:||A multicentre controlled trial of terfenadine, dexchlorpheniramine and placebo in allergic rhinitis|
|Settore Scientifico Disciplinare:||Settore MED/09 - Medicina Interna|
|Data di pubblicazione:||1982|
|Appare nelle tipologie:||01 - Articolo su periodico|